Efficacy of initiating tobacco dependence treatment in inpatient psychiatry: A randomized controlled trial

American Journal of Public Health

Volumn 104, Issue 8, 2014, Pages 1557-1565

  Prochaska, Judith J ^a   Hall, Stephen E ^a   Delucchi, Kevin ^a   Hall, Sharon M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; MALE; MENTAL DISEASE; METHODOLOGY; PATIENT COMPLIANCE; PSYCHIATRIC DEPARTMENT; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; STATISTICS; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; INPATIENTS; MALE; MENTAL DISORDERS; PATIENT COMPLIANCE; PATIENT READMISSION; PSYCHIATRIC DEPARTMENT, HOSPITAL; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 84904280392     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2013.301403     Document Type: Article

References (58)

1. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284 (20):2606-2610.
2. McClave AK, McKnight-Eily LR, Davis SP, Dube SR. Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey. Am J Public Health. 2010;100 (12):2464-2472.
3. Steinberg ML, Williams JM, Ziedonis DM. Financial implications of cigarette smoking among individuals with schizophrenia. Tob Control. 2004;13(2):206.
4. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42.
5. Schroeder SA. A 51-year-old woman with bipolar disorder who wants to quit smoking. JAMA. 2009;301 (5):522-531.
6. Crockford D, Kerfoot K, Currie S. The impact of opening a smoking room on psychiatric inpatient behavior following implementation of a hospital-wide smoking ban. J Am Psychiatr Nurses Assoc. 2009;15 (6):393-400.
7. Robertson ER. I am a psychiatrist at the Hawaii State Hospital. Bates no. 522700931-522700932. Tobacco Documents Online. Available at: http://tobaccodocuments.org/landman/522700931-0932. html. Accessed March 8, 2010.
8. Prochaska JJ, Fletcher L, Hall SE, Hall SM. Return to smoking following a smoke-free psychiatric hospitalization. Am J Addict. 2006;15(1):15-22.
9. Prochaska JJ, Reyes RS, Schroeder SA, Daniels AS, Doederlein A, Bergeson B. An online survey of tobacco use, intentions to quit, and cessation strategies among people living with bipolar disorder. Bipolar Disord. 2011;13(5-6):466- 473.
10. Dickens GL, Stubbs JH, Haw CM. Smoking and mental health nurses: a survey of clinical staff in a psychiatric hospital. J Psychiatr Ment Health Nurs. 2004;11 (4):445-451.
11. Accreditation Manual for Hospitals. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 1992.
12. Foderaro LW. Battling demons, and nicotine hospitals' smoking bans are new anxiety for mentally ill. New York Times. February 19, 1995.
13. House of Commons Health Committee. Smoking in Public Places: First Report of Session 2005-06. Vol HC 485-I. London, UK: Stationery Office Limited; 2005.
14. Lawn S, Pols R. Smoking bans in psychiatric inpatient settings? A review of the research. Aust N Z J Psychiatry. 2005;39(10):866-885.
15. Lane JGM, Werdel MB, Schacht L, Ortiz G, Parks J. Smoking policies and practices in state psychiatric facilities: survey results from 2008. Alexandria, VA: National Assocation of State Mental Health Program Directors Research Institute, Inc; 2009.
16. Prochaska JJ, Gill P, Hall SM. Treatment of tobacco use in an inpatient psychiatric setting. Psychiatr Serv. 2004;55(11):1265-1270.
17. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services; 2008.
18. Rigotti NA, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2007(3):CD001837.
19. Banham L, Gilbody S. Smoking cessation in severe mental illness: what works? Addiction. 2010;105 (7):1176-1189.
20. Brown RA, Ramsey SE, Strong DR, et al. Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders. Tob Control. 2003;12 (suppl 4):iv3-iv10.
21. Practice Guideline for the Treatment of Patients with Substance Use Disorders. 2nd ed. Arlington, VA: American Psychiatric Association; 2006.
22. Prochaska JJ. Ten critical reasons for treating tobacco dependence in inpatient psychiatry. J Am Psychiatr Nurses Assoc. 2009;15(6):404-409.
23. Prochaska JJ, Hall SM, Bero LA. Tobacco use among individuals with schizophrenia: what role has the tobacco industry played? Schizophr Bull. 2008;34(3):555-567.
24. Hall SM, Prochaska JJ. Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psychol. 2009;5:409-431.
25. Evins AE. Review: bupropion increases abstinence from smoking without affecting mental state in people with schizophrenia. Evid Based Ment Health. 2010;13 (4):120.
26. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2010(6): CD007253.
27. Williams JM, Anthenelli RM, Morris CD, et al. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2012;73 (5):654-660.
28. George TP, Vessicchio JC, Sacco KA, et al. A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biol Psychiatry. 2008;63(11):1092-1096.
29. Wu BS, Weinberger AH, Mancuso E, et al. A preliminary feasibility study of varenicline for smoking cessation in bipolar disorder. J Dual Diagn. 2012;8 (2):131-132.
30. Readmissions to California Hospitals, 2005 to 2006. Sacramento, CA: California Office of Statewide Health Planning and Development; 2010.
31. Martinez JM, Marangell LB, Simon NM, et al. Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD. Psychiatr Serv. 2005;56(12):1541-1548.
32. Reichler H, Baker A, Lewin T, Carr V. Smoking among in-patients with drug-related problems in an Australian psychiatric hospital. Drug Alcohol Rev. 2001;20(2):231-237.
33. Siru R, Hulse GK, Tait RJ. Assessing motivation to quit smoking in people with mental illness: a review. Addiction. 2009;104(5):719-733.
34. Haller E, McNiel DE, Binder RL. Impact of a smoking ban on a locked psychiatric unit. J Clin Psychiatry. 1996;57(8):329-332.
35. Prochaska JJ, Velicer WF, Prochaska JO, Delucchi K, Hall SM. Comparing intervention outcomes in smokers treated for single versus multiple behavioral risks. Health Psychol. 2006;25(3):380-388.
36. Gritz ER, Carr CR, Rapkin D, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993;2 (3):261-270.
37. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol. 1992;47(9):1102-1114.
38. Prochaska JJ, Hall SE, Hall SM. Stage-tailored tobacco cessation treatment in inpatient psychiatry. Psychiatr Serv. 2009;60(6):848.
39. Rochon J. Application of GEE procedures for sample size calculations in repeated measures experiments. Stat Med. 1998;17(14):1643-1658.
40. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127.
41. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51 (3):390-395.
42. Hall SM, Havassy BE, Wasserman DA. Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine. J Consult Clin Psychol. 1990;58 (2):175-181.
43. Eisen SV, Normand SL, Belanger AJ, Spiro A 3rd, Esch D. The Revised Behavior and Symptom Identification Scale (BASIS-R): reliability and validity. Med Care. 2004;42(12):1230-1241.
44. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10 (2):77-84.
45. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233.
46. Saunders JB, Aasland OG, Babor TF, De La Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction. 1993;88(6):791-804.
47. Cocco KM, Carey KB. Psychometric properties of the Drug Abuse Screening Test in psychiatric outpatients. Psychol Assess. 1998;10(4):408-414.
48. Blouin AG, Perez EL, Blouin JH. Computerized administration of the Diagnostic Interview Schedule. Psychiatry Res. 1988;23(3):335-344.
49. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003;5(1):13-25.
50. Barnett PG, Wong W, Hall S. The cost-effectiveness of a smoking cessation program for out-patients in treatment for depression. Addiction. 2008;103(5):834-840.
51. Dawood N, Vaccarino V, Reid KJ, Spertus JA, Hamid N, Parashar S. Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success. Arch Intern Med. 2008;168(18):1961-1967.
52. Prochaska JJ, Schane R, Leek D, Hall SE, Hall SM. Investigation into the cause of death of a 56-year-old man with serious mental illness. Am J Psychiatry. 2008;165 (4):453-456.
53. Schafer JL. Analysis of Incomplete Multivariate Data. New York, NY: Chapman and Hall; 1997.
54. Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7(2):147-177.
55. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16(3):219-242.
56. Glasgow RE, Mullooly JP, Vogt TM, et al. Biochemical validation of smoking status: pros, cons, and data from four low-intensity intervention trials. Addict Behav. 1993;18(5):511-527.
57. Velicer WF, Prochaska JO, Rossi JS, Snow MG. Assessing outcome in smoking cessation studies. Psychol Bull. 1992;111(1):23-41.
58. Patten CA, Martin JE, Filter KJ, Wolter TD. Utility and accuracy of collateral reports of smoking status among 256 abstinent alcoholic smokers treated for smoking cessation. Addict Behav. 2002;27(5):687-696.